Quantcast

Latest Evotec Stories

2014-06-18 12:38:03

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Drug Discovery Outsourcing: World Market Forecast 2014-2024 & Future Prospects for Leading Companieshttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/drug_discovery_outsourcing_world_market_forecast_2014_2024_future_prospects_leading_companies.html Report DetailsDrug discovery outsourcing - discover trends and segments with highest revenue potentialWhat does the future hold...

2014-04-29 23:12:36

Informative webinar will provide insight on approaches to phenotypic screening for hit ID in the context of complex and novel biological systems. The live broadcast takes place on Wednesday, May 21, 2014 at 10:00am EDT (15:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 29, 2014 Using phenotypic screens as a strategy to identify potential drug candidates has gained renewed attention in recent years. The aim is to identify chemical matter that corrects disease-relevant cellular...

2014-04-18 23:04:53

Live webinar to focus on using quantitative phosphoproteomics to support the discovery and development of kinase-selective drugs. The broadcast takes place on Wednesday, May 7, 2014 at 10:00am EDT (15:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 18, 2014 The study of phosphoproteomics represents a major leap forward in drug target and mode of action analysis: Deregulated protein kinase signaling occurs in many human diseases such as cancer, inflammatory disorders or neurodegenerative...

2014-04-16 20:22:43

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/btrshd/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts to 2018" [http://www.researchandmarkets.com/research/btrshd/biomarkers_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2014-04-04 23:03:51

The major factors driving the growth of the high content screening (HCS) market include the need for determining the level of toxicity in the early stages of drug discovery pipeline, government support for cell-based research, and the introduction of enhanced informatics solutions and improved image analysis instruments. http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html (PRWEB) April 04, 2014 The “High Content Screening Market by Instruments...

2014-04-02 04:21:07

LAUSANNE, Switzerland and HAMBURG, Germany, April 2, 2014 /PRNewswire/ -- - Innovative partnership based on Evotec's Target X projects - Evotec and Debiopharm to share discovery and development efforts Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today a research collaboration and licensing deal with Debiopharm Group(TM), Lausanne, Switzerland. The objective of this collaboration is to identify and...

2014-03-31 04:20:51

CAMBRIDGE, England, March 31, 2014 /PRNewswire/ -- Convergence Pharmaceuticals Holdings Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has entered into a research alliance with Evotec, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related